Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 17 most recent Form 4 transactions.
| $596.3K |
| -13.5% |
| Open the original filing on SEC.gov |
| May 13 | BCRX | Biocryst Pharmaceuticals… | MEXER◷ | 62,500 | $5.04 | $315K | +15.6% | Open the original filing on SEC.gov |
| Mar 16 | BCRX | Biocryst Pharmaceuticals… | MEXER◷◆ | 150,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 16 | BCRX | Biocryst Pharmaceuticals… | SSELL◷ | 150,000 | $9.15 | $1.4M | -27.2% | Open the original filing on SEC.gov |
| Mar 16 | BCRX | Biocryst Pharmaceuticals… | MEXER◷ | 150,000 | $5.51 | $826.5K | +37.4% | Open the original filing on SEC.gov |
| Dec 22, 2025 | BCRX | Biocryst Pharmaceuticals… | SSELL◷ | 21,773 | $7.65 | $166.6K | -5.2% | Open the original filing on SEC.gov |
| Dec 19, 2025 | BCRX | Biocryst Pharmaceuticals… | FTAX◷ | 16,902 | $7.41 | $125.2K | -3.9% | Open the original filing on SEC.gov |
| Dec 17, 2025 | BCRX | Biocryst Pharmaceuticals… | AGRANT◆ | 255,050 | — | — | — | Open the original filing on SEC.gov |
| Dec 17, 2025 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 121,700 | — | — | +38.6% | Open the original filing on SEC.gov |
| Dec 15, 2025 | BCRX | Biocryst Pharmaceuticals… | SSELL◷ | 21,210 | $7.65 | $162.3K | -6.3% | Open the original filing on SEC.gov |
| Dec 12, 2025 | BCRX | Biocryst Pharmaceuticals… | FTAX◷ | 8,540 | $7.57 | $64.6K | -2.5% | Open the original filing on SEC.gov |
| Dec 3, 2025 | BCRX | Biocryst Pharmaceuticals… | SSELL◷ | 19,770 | $7.65 | $151.2K | -5.4% | Open the original filing on SEC.gov |
| Dec 2, 2025 | BCRX | Biocryst Pharmaceuticals… | SSELL◷ | 50,906 | $7.21 | $367.2K | -12.2% | Open the original filing on SEC.gov |
| Dec 1, 2025 | BCRX | Biocryst Pharmaceuticals… | MEXER◷◆ | 91,004 | — | — | — | Open the original filing on SEC.gov |
| Dec 1, 2025 | BCRX | Biocryst Pharmaceuticals… | SSELL◷ | 91,004 | $7.10 | $646.5K | -17.9% | Open the original filing on SEC.gov |
| Dec 1, 2025 | BCRX | Biocryst Pharmaceuticals… | MEXER◷ | 91,004 | $3.22 | $293K | +21.9% | Open the original filing on SEC.gov |